Deeply honored to assume the Joseph W. Burnett Endowed Professor and Chair of the University of Maryland School of Medicine @UMmedschool Department of Dermatology Very thankful to @HopkinsMedicine. Ready to embark on this new chapter!

Our lab @UMmedschool is excited to share the discovery of a new skin disease - IL-13+ IL-17+ erythroderma. We also obtained a patent on a diagnostic immunophenotyping platform for the treatment of inflammatory skin diseases #dermtwitter @HannahCornman

We are excited to have Dr. Shivani Patel join our dermatology faculty at Maryland @UMmedschool @UMMC and help us grow pediatric dermatology and lead an infantile hemangiomas specialty clinic!

RT @HCPLiveNews: In this video, panelists discuss the psychological burden experienced by patients with chronic spontaneous urticaria. #D…

RT @DermTimesNow: “One of the main themes of our session was every dermatologist, every physician, every provider who takes care of dermato…

#EADV2024 is a huge success. Excited to present on our lab’s contribution to the rapid ongoing translational revolution in novel #itch therapeutics, spanning from IL-4 & IL-13 to IL-31, Jak inhibitors, and Btk inhibitors on the horizon #dermtwitter

Thank you @Medscape for covering my talk over the weekend @SkinOfColorDerm highlighting the incredible progress being made for skin of color patients with seborrheic dermatitis, one of dermatology’s long forgotten diseases #dermtwitter

Had a great time speaking @SkinOfColorDerm this weekend about #itch & seborrheic dermatitis, including recent new FDA approvals that are changing the management landscape #dermtwitter

RT @UMmedschool: Dr. Shawn Kwatra led a compelling study that found low levels of metabolite biomarkers in the blood plasma of patients w/…

The itch world woke up on 🔥 this morning with the FDA approval of #nemolizumab for #prurigo nodularis (PN). It was an honor to serve as the lead investigator of the Olympia program resulting in a breakthrough therapy for #PN patients #dermtwitter #itch

Happy to share my lab’s real-world precision medicine study on dupilumab treatment reversing circulating blood inflammation and mediators of fibrosis in prurigo nodularis patients #itch #dermtwitter

Excited to share our report in @JAADjournals on a unique phenotype of chronic itch developing following immune stimulus exposure, be it viral flare, vaccination, or drug exposure, w/ a mechanistic role for elevated circulating blood type 2 inflammation

RT @theJIDJournal: Single-cell RNA sequencing reveals dysregulated POSTN+WNT5A+ fibroblast subclusters in prurigo nodularis

Had a great 4th of July in 🇬🇧@BritishDermDocs at the 104th Annual Meeting of the British Association of Dermatologists. Also enjoyed visiting Leeds Hospital @NHSEngland to give grand rounds on chronic itch from atopic dermatitis to prurigo & beyond #BAD2024 #dermtwitter

I am thrilled to announce Dr. Aisha Mumtaz will be joining the Department of Dermatology @UMmedschool! Dr. Mumtaz joins us from Mount Sinai Dermatology @MSHSDerm and will direct a first of its kind oculocutaneous diseases specialty clinic #dermtwitter

RT @HarrisTryonLab: Join me and my fellow program chairs at the 71st Annual Montagana Symposium, titled “Skin of Color Dermatology: The Int…

RT @debkotz2: @UMmedschool dermatology chair @drshawnkwatra published important new finding in @JAMADerm on promising new treatment for in…

So excited to announce Kristin Khan, MD as the first new dermatology recruit under my tenure @UMmedschool. Dr. Khan has specialty expertise in acne, rosacea, & seborrheic dermatitis and will serve our educational mission as APD & Director of Medical Student Education.

Had a great weekend speaking at the 2024 Congress of Clinical Dermatology in Amelia Island. Great conference and enjoyed sharing the latest advances in itch diagnosis and therapeutics.

Excited to kick off at @SocInvestDerm with a talk on the OX40 Ligand Pathway. Come join some of our lab’s talks #eczema #prurigo #SID2024Dallas @JayaManjunath1